Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Jaguar Health, Inc.

NASDAQ: JAGXHealthcare / Biotechnology / USA
0.160000.00Vol 1 574 9581Y Perf -95.08%
Mar 15th, 2019 16:00
BID0.1500 ASK0.1600
Open0.1500 Previous Close0.1600
Pre-Market- After-Trading-
 - -%  - -%
Target Price
1.25 
Analyst Rating
— 0.00
Potencial %
681.25 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
     37.02
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)10 
Earnings Rating
Neutral
Price Range Ratio 52wk %
1.17 
Earnings Date
18th Mar 2019

Today's Price Range

0.15000.1700

 

52wk Range

0.12003.53

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-33.33%
3 Months
-48.39%
6 Months
-70.37%
1 Year
-95.08%
3 Years
-99.38%
5 Years
-

Name / TickerPriceChg.Chg.%
JAGX0.16000.00000.00
AAPL186.122.39001.30
GOOG1 184.46-1.0900-0.09
MSFT115.911.32001.15
XOM80.15-0.2900-0.36
WFC50.660.31000.62
JNJ137.62-0.4000-0.29
FB165.98-4.1900-2.46
GE9.96-0.3400-3.30
JPM106.551.21001.15
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.10
Current Ratio
0.50
Long Term Debt to Total Capital
0.51
Total Debt to Equity
1.57
Interest Coverage
-14.70
Leverage Ratio 3.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
44.00
EBIT Margin
-873.30
EBITDA Margin
-844.70
Pre-tax Profit Margin
-
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 820
Revenue per Share
0.04
Revenue Growth 3 Years
156.09
Revenue Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2017-0.13-
Q02 2017-0.22-0.1245.45
Q01 2017--0.28-
Q03 2016-0.40-0.3025.00
Q02 2016-0.42-0.3516.67
Q01 2016-0.49-0.4312.24
Q03 2015-0.49-0.3626.53
Q02 2015--0.97-
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.130.00-
12/2017 QR-0.070.00-
12/2017 FY-0.17-142.86Negative
12/2018 FY-0.09-50.00Negative
Next Report Date18th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 574 958
Shares Outstanding (in ths.)64 904
Trades Count975
Dollar Volume217 188
Avg. Volume901 862
Avg. Weekly Volume2 488 474
Avg. Monthly Volume1 583 099
Avg. Quarterly Volume839 565

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

56%44%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News